Print this page    •   Back to Web version of article

International News
IPS Examines Reaction to Introduction of Fixed-Dose ARVs in South Africa

May 6, 2013

Noting "a serious supply shortage [of antiretroviral (ARV) treatment in South Africa last May], the most recent of several stockouts that have plagued the state-funded ARV treatment program since its launch in 2004," Inter Press Service examines reaction to the introduction of fixed-dose ARVs (FDAs) in the country last month. The news service notes, "Until now, state-funded ARV treatment has comprised three different pills taken at different times during the day. The new FDA combines the three key agents from these pills in a single pill that only needs to be taken once a day."

"Although welcoming the FDAs as easier and more convenient for patients, activists and health professionals alike have warned that a stockout of the drug could have a catastrophic effect on the country's public HIV/AIDS treatment program -- the largest of its kind in the world," IPS continues. "The risk of FDAs is that there isn't really a good fall-back," Kevin Rebe of the Anova Health Institute, "which runs the Health4Men program focusing on HIV prevention and treatment," tells IPS, the news service writes, adding, "He points out that even a few missed doses could result in resistance to treatment." However, the news service notes, "The introduction of FDAs is also expected to significantly reduce the state's annual bill for HIV/AIDS treatment" (Bendix, 5/6).

Back to other news for May 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/71436/ips-examines-reaction-to-introduction-of-fixed-dos.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.